Physician profile
David Keeven
NPI 1841759289
$1,888.89
in general payments reported to CMS, 2019-2025
12 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 78% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $65.32 · 2022: $59.79 · 2023: $229 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,000 · Food and Beverage: $764.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,000.00 |
| Food and Beverage | $763.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,000.00 | 2025 | |
| Avita Medical Americas, LLC | $334.22 | 2025 | Permeaderm, Recell, Cohealyx |
| Silk Road Medical, INC. | $167.22 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Enterra Medical, INC. | $111.61 | 2025 | |
| Boston Scientific Corporation | $82.65 | 2022-2023 | |
| Integra Lifesciences Corporation | $44.41 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Pfizer INC. | $41.40 | 2021 | |
| Abbvie INC. | $24.33 | 2025 | |
| Genzyme Corporation | $23.92 | 2021 | |
| Mallinckrodt Hospital Products INC. | $22.75 | 2022 | |
| Polynovo North America LLC | $20.15 | 2025 | Novosorb Btm |
| Smith+Nephew, INC. | $16.23 | 2023 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Keeven listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.